182 related articles for article (PubMed ID: 1411405)
1. [Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
Stoll T; Michel BA; Neidhart M; Wassmer P; Neidl K; Fehr K; Wagenhäuser FJ
Schweiz Med Wochenschr; 1992 Sep; 122(39):1458-65. PubMed ID: 1411405
[TBL] [Abstract][Full Text] [Related]
2. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
Chérin P; Herson S
Ann Med Interne (Paris); 1993; 144(8):521-5. PubMed ID: 8179241
[TBL] [Abstract][Full Text] [Related]
3. Treatment of polymyositis and dermatomyositis.
Kaye SA; Isenberg DA
Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
[TBL] [Abstract][Full Text] [Related]
4. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
[TBL] [Abstract][Full Text] [Related]
5. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
Cherin P
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of steroid-resistant polymyositis and dermatomyositis].
Mimura T; Kanda H; Kubo K
Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
[TBL] [Abstract][Full Text] [Related]
8. [Dermatomyositis and polymyositis: clinical aspects and treatment].
Hachulla E
Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
[TBL] [Abstract][Full Text] [Related]
9. [Current therapy for polymyositis and dermatomyositis].
Chérin P
Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
[TBL] [Abstract][Full Text] [Related]
10. [Intravenous immunoglobulins in polymyositis and dermatomyositis].
Chérin P; Herson S
Rev Med Interne; 1999; 20 Suppl 4():436s-439s. PubMed ID: 10522319
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
[TBL] [Abstract][Full Text] [Related]
12. The role of MRI in the assessment of polymyositis and dermatomyositis.
Tomasová Studynková J; Charvát F; Jarosová K; Vencovsky J
Rheumatology (Oxford); 2007 Jul; 46(7):1174-9. PubMed ID: 17500079
[TBL] [Abstract][Full Text] [Related]
13. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis].
Breems DA; de Haas PW; Visscher F; Sabbe LJ; Busch HF; van Doorn PA
Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1979-82. PubMed ID: 8413708
[TBL] [Abstract][Full Text] [Related]
14. [A case of steroid-resistant polymyositis who made a good response to high dose intravenous immunoglobulins (IVIG)].
Saito M; Saito Y; Endo K; Tanaka M
Rinsho Shinkeigaku; 2000 Feb; 40(2):181-3. PubMed ID: 10835943
[TBL] [Abstract][Full Text] [Related]
15. Potential therapeutic targets for idiopathic inflammatory myopathies.
De Bleecker JL; Creus KK; De Paepe B
Drug News Perspect; 2006 Nov; 19(9):549-57. PubMed ID: 17220960
[TBL] [Abstract][Full Text] [Related]
16. Rituximab as therapy for refractory polymyositis and dermatomyositis.
Noss EH; Hausner-Sypek DL; Weinblatt ME
J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
[TBL] [Abstract][Full Text] [Related]
17. [New therapeutic approaches for polymyositis and dermatomyositis].
Dankó K; Vincze M
Orv Hetil; 2011 Sep; 152(39):1552-9. PubMed ID: 21920841
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
Pongratz D
J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin therapy for refractory myositis.
Moriguchi M; Suzuki T; Tateishi M; Hara M; Kashiwazaki S
Intern Med; 1996 Aug; 35(8):663-7. PubMed ID: 8894745
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis.
Marie I; Hachulla E; Levesque H; Reumont G; Ducrotte P; Cailleux N; Hatron PY; Devulder B; Courtois H
J Rheumatol; 1999 Dec; 26(12):2706-9. PubMed ID: 10606390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]